Partner with our team in Cologne.
BIO-Europe returns to Koelnmesse in Cologne from 9–11 November 2026, bringing together biotech, pharma, and investment leaders from more than 60 countries for Europe’s flagship life sciences partnering event. With thousands of attendees and a programme that now stretches beyond one-to-one partnering into regulatory strategy, clinical affairs, and manufacturing, it remains the most efficient place to open conversations that move programmes forward.
OCT Clinical will be represented in Cologne by Varvara Melnikova, Head of Business Development.
Our team supports biotech and pharma companies through early-phase design, late-stage execution, site selection, and regulatory submission across a range of solid tumour and haematology indications. If you are preparing a study and want a straightforward view on European feasibility, startup timelines, or patient access, we are offering complimentary feasibility assessments during the congress.
To arrange a meeting in Cologne, contact vmelnikova@octclinicalgroup.com. Whether your priority is trial design, site strategy, study management, or registration planning, we are happy to sit down and talk through what would actually help your programme.
